Moreover, different tau mutations, and animal and cellular models of tauopathy have historically shown variable degrees of neuronal UPR activation as determined by markers’, such as P-PERK, levels associated with P-Tau accumulation [262]. The gene discussed is MAPT; the disease is tauopathy.